AbbVie Inc. (ABBV)

Last Price: 107.73 (2021-09-17)

Company Description

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $45.80B
Net Income (Most Recent Fiscal Year) $4.62B
PE Ratio (Current Year Earnings Estimate) 8.52
PE Ratio (Trailing 12 Months) 9.12
PEG Ratio (Long Term Growth Estimate) 2.03
Price to Sales Ratio (Trailing 12 Months) 3.54
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 15.12
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 7.84
Pre-Tax Margin (Trailing 12 Months) 11.21%
Net Margin (Trailing 12 Months) 12.40%
Return on Equity (Trailing 12 Months) 154.24%
Return on Assets (Trailing 12 Months) 14.10%
Current Ratio (Most Recent Fiscal Quarter) 0.91
Quick Ratio (Most Recent Fiscal Quarter) 0.79
Debt to Common Equity (Most Recent Fiscal Quarter) 5.89
Inventory Turnover (Trailing 12 Months) 5.50
Book Value per Share (Most Recent Fiscal Quarter) $7.42
Earnings per Share (Most Recent Fiscal Quarter) $3.11
Earnings per Share (Most Recent Fiscal Year) $10.56
Diluted Earnings per Share (Trailing 12 Months) $3.71
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - General
Common Shares Outstanding 1.77B
Free Float 1.77B
Market Capitalization $190.38B
Average Volume (Last 20 Days) 9.29M
Beta (Past 60 Months) 0.82
Percentage Held By Insiders (Latest Annual Proxy Report) 0.09%
Percentage Held By Institutions (Latest 13F Reports) 65.82%
Annual Dividend (Based on Last Quarter) $5.20
Dividend Yield (Based on Last Quarter) 4.83%